ID: ALA1099117

Max Phase: Preclinical

Molecular Formula: C14H18N4O4

Molecular Weight: 306.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(COc2cc(N)nc(N)n2)cc(OC)c1OC

Standard InChI:  InChI=1S/C14H18N4O4/c1-19-9-4-8(5-10(20-2)13(9)21-3)7-22-12-6-11(15)17-14(16)18-12/h4-6H,7H2,1-3H3,(H4,15,16,17,18)

Standard InChI Key:  FQPLKBGCLFVAAZ-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase 1637 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dihydrofolate reductase 1239 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dihydrofolate reductase 2343 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dihydrofolate reductase 350 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.32Molecular Weight (Monoisotopic): 306.1328AlogP: 1.25#Rotatable Bonds: 6
Polar Surface Area: 114.74Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.11CX LogP: 1.35CX LogD: 1.17
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.82Np Likeness Score: -0.25

References

1. Bag S, Tawari NR, Degani MS, Queener SF..  (2010)  Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens.,  18  (9): [PMID:20363634] [10.1016/j.bmc.2010.03.031]

Source